Figure 1From: Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy Study plan optimizing clopidogrel treatment without prasugrel. (Prasugrel not available or contraindicated). Platelet function assay (if treatment ineffective, next step), Tx indicates treatment; high clopidogrel dose of 150 mg daily, ticlopidine 2 × 250 mg daily.Back to article page